I agree that this site is using cookies. You can find further informations here.
X
Gerbens, L.A.
327  results:
Search for persons X
?
1

First update of the living European guideline (EuroGuiDerm)..:

Wollenberg, A. ; Kinberger, M. ; Arents, B....
Journal of the European Academy of Dermatology and Venereology.  37 (2023)  11 - p. , 2023
Link: https://doi.org/10.1111/..
 
?
2

Implementation of the HOME core outcome set for clinical tr..:

Jacobson, M. E. ; Thomas, K. S. ; Apfelbacher, C. J....
Archives of Dermatological Research.  315 (2023)  9 - p. 2617-2622 , 2023
Link: https://doi.org/10.1007/..
 
?
3

Real‐world reported adverse events related to systemic immu..:

Musters, A. H. ; van Lookeren, F. L. ; van der Gang, L. F....
Journal of the European Academy of Dermatology and Venereology.  38 (2023)  3 - p. 530-542 , 2023
Link: https://doi.org/10.1111/..
 
?
4

Phototherapy for atopic dermatitis: A survey of European pr..:

Steyn, M. ; Gerbens, L. A. A. ; Spuls, P. I....
Journal of the European Academy of Dermatology and Venereology.  38 (2023)  3 - p. 521-529 , 2023
Link: https://doi.org/10.1111/..
 
?
5

European guideline (EuroGuiDerm) on atopic eczema: part I –..:

Wollenberg, A. ; Kinberger, M. ; Arents, B....
Journal of the European Academy of Dermatology and Venereology.  36 (2022)  9 - p. 1409-1431 , 2022
Link: https://doi.org/10.1111/..
 
?
6

European guideline (EuroGuiDerm) on atopic eczema – part II..:

Wollenberg, A. ; Kinberger, M. ; Arents, B....
Journal of the European Academy of Dermatology and Venereology.  36 (2022)  11 - p. 1904-1926 , 2022
Link: https://doi.org/10.1111/..
 
?
7

Do patient characteristics matter when calculating sample s..:

Howells, L. ; Gran, S. ; Chalmers, J. R....
Skin Health and Disease.  1 (2021)  3 - p. , 2021
Link: https://doi.org/10.1002/..
 
?
8

Recommended core outcome instruments for health‐related qua..:

Thomas, K.S. ; Apfelbacher, C.A. ; Chalmers, J.R....
British Journal of Dermatology.  185 (2021)  1 - p. 139-146 , 2021
Link: https://doi.org/10.1111/..
 
?
9

Paternal and maternal use of dupilumab in patients with ato..:

Bosma, A. L. ; Gerbens, L. A. A. ; Middelkamp‐Hup, M. A..
Clinical and Experimental Dermatology.  46 (2021)  6 - p. 1089-1092 , 2021
Link: https://doi.org/10.1111/..
 
?
10

Effectiveness of dupilumab treatment in 95 patients with at..:

Wijs, L.E.M. ; Bosma, A.L. ; Erler, N.S....
British Journal of Dermatology.  182 (2020)  2 - p. , 2020
Link: https://doi.org/10.1111/..
 
?
11

The European TREatment of ATopic eczema (TREAT) Registry Ta..:

Vermeulen, F.M. ; Gerbens, L.A.A. ; Schmitt, J....
British Journal of Dermatology.  183 (2020)  6 - p. 1073-1082 , 2020
Link: https://doi.org/10.1111/..
 
?
12

TREatment of ATopic eczema (TREAT) Registry Taskforce: meth..:

Bosma, A.L. ; Spuls, P.I. ; Garcia‐Doval, I....
British Journal of Dermatology.  182 (2020)  6 - p. , 2020
Link: https://doi.org/10.1111/..
 
?
13

特应性湿疹的治疗 (TREAT) 登记工作组:比较 Dupilumab 与其他全身药物治疗中度至重度湿疹安全性的方法:

Bosma, A.L. ; Spuls, P.I. ; Garcia‐Doval, I....
British Journal of Dermatology.  182 (2020)  6 - p. , 2020
Link: https://doi.org/10.1111/..
 
?
14

Dupilumab 治疗 95 例特应性皮炎患者的有效性:日常实践数据:

Wijs, L.E.M. ; Bosma, A.L. ; Erler, N.S....
British Journal of Dermatology.  182 (2020)  2 - p. , 2020
Link: https://doi.org/10.1111/..
 
?
15

Recommended core outcome instruments for health‐related qua..:

Thomas, K.S. ; Apfelbacher, C.A. ; Chalmers, J.R....
British Journal of Dermatology.  , 2020
Link: https://doi.org/10.1111/..
 
1-15